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We report that the metazoan Wnt protease and signaling inhibitor TIKI shares sequence homology with
bacterial TraB/PrgY proteins, inhibitors of pheromone signaling essential for propagation of antibiotic resis-
tance. Our analysis suggests that these proteins represent an ancientmetalloprotease clan regulating cellular
communications across biological kingdoms.Signaling by the secreted Wnt family of
morphogens has essential functions in
animal development and homeostasis.
Diverse mechanisms of regulating auto-
crine and paracrine Wnt signaling have
evolved, mostly involving actions of pro-
teins that block the assembly of the
Wnt-Frizzled-LRP5/6 receptor signaling
complex or inhibit cell-to-cell movement
of Wnts (MacDonald et al., 2009). The
discovery of the membrane-tethered
TIKI metalloprotease reveals a distinct
mode of attack by cleaving the amino
terminus of mature Wnt proteins, thereby
inactivating the Wnt ligand (Zhang et al.,
2012) (Figure 1A). Provocatively, TIKI
proteins display sequence homology
with the recently merged TraB/PrgY/
gumN family of bacterial proteins
(PFAM families PF01963 and PF07446).
The biochemical nature of TraB/PrgY
from the gut flora Enterococcus faecalis,
like that of gumN from the plant path-
ogen Xanthomonas, has not been char-
acterized (Chandler and Dunny, 2004,
2008).
Enterococcus faecalis is a multidrug-
resistant pathogen and common source
for hospital infections. These bacteria
harbor plasmids that carry antibiotic
resistance genes, and they transfer
these plasmids and thus antibiotic resis-
tance through mating conjugation (Chan-
dler and Dunny, 2004). Mating is initiated
by a pheromone (usually a hepta- or
octa-peptide) that functions to induce
the expression of plasmid-encoded con-
jugation factors, which mediate mating(Figure 1A). Self-induction (mating be-
tween bacteria that already harbor the
plasmid) is unproductive and energy
consuming and is suppressed by two
plasmid-encoded factors (Figure 1A): an
inhibitor peptide that antagonizes the
pheromone, and the transmembrane
protein TraB/PrgY, which reduces the
pheromone level or activity via an un-
known mechanism (Chandler and Dunny,
2004, 2008). Multiple mating phero-
mones exist, and multiple versions of
the inhibitor peptide and TraB/PrgY are
encoded by these plasmids, conferring
the bacterium with exquisite regulation
of its specificity and sensitivity to a given
pheromone (Chandler and Dunny, 2004).
Based on homology with TIKI proteins, it
appears likely that TraB/PrgY acts as a
protease to inactivate the mating phero-
mone (Figure 1A). The existence of TraB/
PrgY and the inhibitor in the bacterial
pheromone response pathway bears
striking functional parallels to that of
TIKI and Wnt antagonists in mor-
phogen signaling in animal development
(Figure 1A).
The human TIKI ectodomain features
an amino-terminal region of 330 resi-
dues, which is predicted to be globular
and rich in secondary structure
(Figure 1B) and is homologous to pre-
dicted TraB/PrgY products, as these
proteins are each marked by a pair of
widely spaced GX2H motifs and a
conserved glutamate (PFAM PF01963)
(see Figure S1A available online). To un-
cover the corresponding catalytic siteDevelopmental Celsignposts in TIKI, we employed a struc-
ture-aided method (Pei et al., 2008) to
accurately align representative TIKI and
TraB/PrgY proteins and also sought a
three-dimensional template for the family
by sensitive fold recognition and struc-
ture prediction methods (So¨ding, 2005).
These efforts reliably identified a distant
fold match for TIKI and TraB/PrgY pro-
teins with a small group of enigmatic pro-
teins, referred to as ‘‘EreA/ChaN-like’’ by
the SCOP domain fold database. EreA is
an erythromycin esterase (PDB 2QGM
and 3B55) (Morar et al., 2012), and
ChaN (PDB 2G5G) is a putative heme-
transport protein (Chan et al., 2006).
The most compact version of the EreA/
ChaN-like a+b fold is present in the C2
domain of a bacterial (Pasteurella multo-
cida) toxin (PMT; PDB 2EBF); this
domain of unknown function is fused to
a carboxyl terminal Cys-protease module
(Kitadokoro et al., 2007). Comparison of
these available structures shows a
conserved parallel b sheet core (with he-
lices packed on both sides) with a vari-
able N-terminal end and distinct helical
inserts into a central loop, with the differ-
ences manifesting as divergent embel-
lishments to the core (Figures 1C and
1D). Intriguingly, a series of con-
served amino acids (His39, Glu66,
Glu140, Arg283, Asn284, and His311 in
human TIKI1) map to the putative
active site pocket in the core (Figures
1C and S1A), implying a catalytic assem-
bly for the TIKI metalloprotease and
TraB/PrgY proteins. This core hasl 25, May 13, 2013 ª2013 Elsevier Inc. 225
Figure 1. TIKI and TraB/PrgY Proteins and Links to an Ancient Metalloprotease Fold
(A) Comparisons of the mechanism of action by which TIKI cleaves and inactivates Wnt ligands in animals versus that we propose for TraB/PrgY in cleavage and
inactivation of the mating pheromone in Enterococcus bacteria (reviewed by Chandler and Dunny, 2004). TIKI cleavesWnts in the secretory pathway/vesicle and
on the cell surface. The functional parallel extends to Wnt antagonists (sFRP and DKK) and the bacterial pheromone inhibitor.
(B) Structural organization of TIKI reveals a globular ectodomain (purple) rich in secondary structures (predicted by PsiPRED; red peaks are helices, green peaks
mark b strands). A set of b strands, labeled A to F (black arrows), and conserved putative active site residues (on top) are highlighted.
(C) The predicted a+b fold architecture of the TIKI domain. b strands A to F form a largely parallel b sheet core that clusters conserved putative active site residues
(also see Figure S1A).
(D) The predicted TIKI domain fold topology is related to an ancestral core b sheet fold found in EreA, ChaN, and PMT C2 domain proteins (PDB 2QGM,
3B55, 2G5G, and 2EBF, respectively). Additional structural embellishments (gray helical insert in EreA), ligands (red metal ion in EreA and bound heme in
ChaN), and chain insertions (red stars) are depicted. Red dashed boxes show predicted regions of fold divergence between TIKI and EreA/ChaN/PMT
C2 domains (see also Figure S1B). The divergent b strand topologies of the latter group, as highlighted by diagrams above the respective structures, contrast
with the tight b-hairpin turn between antiparallel bA and bB strands predicted in TIKI/TraB proteins (C); notably, the PMT C2 C-terminal bA strand serves as
template for the TIKI bA strand. These peripheral zones of topological divergence do not impact the respective active site pockets. An example of a minimal
a/b fold of the core TIKI/TraB/PrgY topology, without inserts, embellishments, and metal-coordinating residues, is exhibited by the domain structure of Sua5
(PFAM code PF03481; PDB 2YV4, from hyperthermophilic archaeon P. horikoshii), whose biochemical function is unknown. Protein graphics composed by
Pymol 1.5 (http://www.pymol.org).
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Forumdegenerated in PMT and other C2-
related domains in MARTX-type bacterial
toxins (Figure S1B).
The best model for TIKI catalytic func-
tion comes from EreA enzymes, in which226 Developmental Cell 25, May 13, 2013 ª2the esterase active site (for macrolide
antibiotic hydrolysis) has been crystal-
lized with a bound, though indistinct,
metal ion (Morar et al., 2012) (Figure S1C).
This appears to be consistent with the013 Elsevier Inc.observed dependence of the TIKI prote-
ase activity on metals (Mn2+ or Co2+, but
not Ni2+, Cu2+, or Zn2+ ions) (Zhang
et al., 2012). Catalytic core residues of
EreA are matched by PDBSiteScan
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dinating catalytic geometry of carboxy-
peptidase A4 (Gomis-Ru¨th, 2008). A cor-
responding model for TIKI1 suggests
that the conserved Glu140 at the end
of b strand D (Figure S1A) acts as the
general base or acid in the catalytic
reaction that enlists an activated water
molecule in the nucleophilic attack of the
scissile peptide bond in substrates (i.e.,
Wnts) (Figure S1C). Like carboxypepti-
dase A4, TIKI1 features a similar helix-
positioned Arg283-Asn284 pair (Arg-
Asp in TraB/PrgY proteins) that could
act to stabilize the substrate chain
(Gomis-Ru¨th, 2008). However, the EreA-
like TIKI active site is embedded in a
metalloprotease fold that is unrelated
to carboxypeptidase A4 and other
metalloenzymes.
We propose that the TIKI/TraB/PrgY
superfamily represents an ancient metal-
loprotease clan with a common protein
architecture––cobbled from the folds of
the EreA/ChaN/PMT group––that medi-
ates proteolytic activities. These struc-tural insights should facilitate under-
standing of how TIKI and TraB/PrgY
proteins specifically recognize and
cleave their respective Wnt and phero-
mone substrates and drive thera-
peutic targeting of these enzymes for
pathogenesis associated with abnormal
Wnt signaling or bacterial antibiotic
resistance.
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